Stocks like TTWO, GMED, ROK, CNQ and VICI stand out with strong sales growth expectations despite market uncertainty.
This medical products stock breaks out of a cup-with-handle base and is in a buy zone. The company makes technology used for spine surgery.
After reaching an important support level, Globus Medical, Inc. (GMED) could be a good stock pick from a technical perspective. GMED recently experienced a "golden cross" event, which saw its 50-day s
PARR, AU, GMED, ALNT and SNDK emerge as top picks after posting gains, rising estimates and sustained relative price outperformance.
Globus Medical (GMED) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Globus Medical's spine business is a big earnings driver, propelling its stock closer to a buy point.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Globus Medical: Straightening Its Back

10:00am, Tuesday, 11'th Nov 2025
Globus Medical has rebounded strongly, driven by accelerating earnings and successful integration of acquisitions like NuVasive and Nevro. The company delivered on robust Q3 results, with 7% organic g
Shares of the medical technology company are headed for their largest same-day percentage increase on record.
The image featured for this article is © Thinkstock
Globus Medical, Inc. ( GMED ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Brian Kearns - Senior Vice President of Business Development & Investor Relations Keith Pfeil - CE
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Stre
Globus Medical (GMED) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $0.83 per share a year ago.

Globus Medical Reports Third Quarter 2025 Results

04:15pm, Thursday, 06'th Nov 2025
AUDUBON, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE